Monoclonal antibodies can similarly mediate the entry of pseudotyped coronavirus into FcγR-expressing cells and trigger the release of proinflammatory cytokines that exacerbate severe COVID-19 (37). The gene discussed is FCGR2A; the disease is COVID-19.